Abstract:Background: Idiopathic pulmonary fibrosis (IPF) is a chronic and fatal pulmonary interstitial disease that usually occurs in the elderly. The senescence of alveolar epithelial cells (AECs) is an important mechanism of IPF. The AECs of patients with IPF have lower expression of peroxisome proliferator-activated receptor-gamma coactivator-1 alpha (PGC-1 alpha), which has been shown to play an important role in maintaining mitochondrial morphology and energy metabolism. This study sought to explore the mechanism by which ZLN005 improves mitochondrial function by upregulating PGC-1 alpha to protect AECs from aging.Methods: Western blot was used to detect the expression of PGC-1 alpha, mitochondrial synthesis protein nuclear respiratory factor-1 (NRF-1), and p21(WAF1) in the lung tissue of the IPF patients and the mice with bleomycin (BLM)-induced pulmonary fibrosis. A549 cells and mice AEC2 cells were treated with hydrogen peroxide (H2O2) to construct cell senescence models. Cell senescence was detected by senescence-associated beta-galactosidase staining. The mitochondrial respiratory function was measured, including the adenosine triphosphate (ATP) generation, reactive oxygen species (ROS) level, changes in cell membrane potential, and energy metabolism. Using lentivirus as a vector and using gene editing technology to over express (upPGC-1 alpha) and knockdown PGC-1 alpha (shPGC-1 alpha) in the A549 cells. The PGC-1 alpha agonist ZLN005 was used to pretreat the A549 and shPGC-1 alpha A549 cells, and cell aging and mitochondrial respiratory function were observed.Results: The Western blot and immunofluorescence assays showed that the expression of PGC-1 alpha and NRF-1 was decreased in the lung tissues of the IPF patients and BLM-induced mice pulmonary fibrosis model, while the expression of p21(WAF1 )was increased. The results of the immunofluorescence and mitochondrial function experiments also indicated that the expression of PGC-1 alpha and mitochondrial synthesis protein NRF-1 were decreased in the senescent cells. Further, the mitochondrial morphology was abnormal and the mitochondrial function was impaired. PGC-1 alpha was involved in the AEC senescence by regulating mitochondrial morphology and function. Treatment with the agonist of PGC-1 alpha (i.e., ZLN005) blocked the H2O2-induced cell senescence by enhancing the expression of PGC-1 alpha.Conclusions: These results provide preliminary insights into the potential clinical application of ZLN005 as a novel therapeutic agent for the treatment of IPF.

Efficacy of YAP1-gene Knockdown to Inhibit Alveolar-Epithelial-Cell Senescence and Alleviate Idiopathic Pulmonary Fibrosis (IPF).

YAP Alleviates Pulmonary Fibrosis Through Promoting Alveolar Regeneration via Modulating the Stemness of Alveolar Type 2 Cells

YAP1 inhibits the senescence of alveolar epithelial cells by targeting Prdx3 to alleviate pulmonary fibrosis

Blockade of YAP alleviates hepatic fibrosis through accelerating apoptosis and reversion of activated hepatic stellate cells.

YAP/TAZ Signaling in the Pathobiology of Pulmonary Fibrosis

YAP1 silencing attenuated lung injury/fibrosis but worsened diaphragmatic function by regulating oxidative stress and inflammation response in mice

Up-regulation of FOXD1 by YAP Alleviates Senescence and Osteoarthritis.

HIP/PAP Protects Against Bleomycin-Induced Lung Injury and Inflammation and Subsequent Fibrosis in Mice.

Loss of ANT1 Increases Fibrosis and Epithelial Cell Senescence in Idiopathic Pulmonary Fibrosis.

Epithelial Yap/Taz are required for functional alveolar regeneration following acute lung injury

The Hippo/YAP1 Pathway Interacts with FGFR1 Signaling to Maintain Stemness in Lung Cancer.

ZLN005 Improves the Protective Effect of Mitochondrial Function on Alveolar Epithelial Cell Aging by Upregulating PGC-1

Inhibition of AHNAK nucleoprotein 2 alleviates pulmonary fibrosis by downregulating the TGF-1/Smad3 signaling pathway

Blockade of ZFX Alleviates Hypoxia-Induced Pulmonary Vascular Remodeling by Regulating the YAP Signaling

ZLN005 improves the protective effect of mitochondrial function on alveolar epithelial cell aging by upregulating PGC-1α

Inhibition of AHNAK nucleoprotein 2 alleviates pulmonary fibrosis by downregulating the TGF-β1/Smad3 signaling pathway

Inhibition of YAP1 activity ameliorates acute lung injury through promotion of M2 macrophage polarization

Epithelial cell senescence induces pulmonary fibrosis through Nanog-mediated fibroblast activation

Curcumin analogue EF24 prevents alveolar epithelial cell senescence to ameliorate idiopathic pulmonary fibrosis via activation of PTEN

Critical role of PAFR/YAP1 positive feedback loop in cardiac fibrosis

Modulating in vitro lung fibroblast activation via senolysis of senescent human alveolar epithelial cells